应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DFTX Definium Therapeutics
已收盘 05-06 16:00:00 EDT
23.42
+1.02
+4.55%
盘后
23.00
-0.42
-1.79%
19:50 EDT
最高
23.53
最低
22.46
成交量
151.29万
今开
22.46
昨收
22.40
日振幅
4.75%
总市值
25.53亿
流通市值
24.12亿
总股本
1.09亿
成交额
3,490万
换手率
1.47%
流通股本
1.03亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Definium Therapeutics 研发DT120口腔崩解片 针对广泛性焦虑症、重度抑郁症及其他严重脑健康疾病
美股速递 · 04-19
Definium Therapeutics 研发DT120口腔崩解片 针对广泛性焦虑症、重度抑郁症及其他严重脑健康疾病
Piper Sandler 首予 Definium Therapeutics 增持评级,目标价49美元
美股速递 · 04-10
Piper Sandler 首予 Definium Therapeutics 增持评级,目标价49美元
Definium Therapeutics现金储备雄厚:截至2025年底持有4.116亿美元现金及投资,预计可支撑运营至2028年
美股速递 · 02-27
Definium Therapeutics现金储备雄厚:截至2025年底持有4.116亿美元现金及投资,预计可支撑运营至2028年
加载更多
公司概况
公司名称:
Definium Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Definium Therapeutics, Inc.于2010年根据不列颠哥伦比亚省法律成立。他们是一家处于后期阶段的临床生物制药公司,正在开发新的候选产品来治疗大脑健康障碍。他们的使命是通过将科学的严谨性应用于迷幻药,锻造精神病学的新时代,目标是开发可获得的治疗方法,以大规模解锁愈合。他们正在开发一系列针对神经递质通路的创新候选产品,这些通路在大脑健康疾病中发挥着关键作用。
发行价格:
--
{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":23.42,"timestamp":1778097600000,"preClose":22.4,"halted":0,"volume":1512866,"hourTrading":{"tag":"盘后","latestPrice":23,"preClose":23.42,"latestTime":"19:50 EDT","volume":48145,"amount":1126756.8307,"timestamp":1778111425406,"change":-0.42,"changeRate":-0.017933,"amplitude":0.017933},"delay":0,"changeRate":0.04553571428571443,"floatShares":103000000,"shares":109000000,"eps":-2.059999,"marketStatus":"已收盘","change":1.02,"latestTime":"05-06 16:00:00 EDT","open":22.46,"high":23.525,"low":22.46,"amount":34904706.681194,"amplitude":0.047545,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.059999,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1778140800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":22.4,"preHourTrading":{"tag":"盘前","latestPrice":22.46,"preClose":22.4,"latestTime":"09:29 EDT","volume":976,"amount":21922.739247999998,"timestamp":1778074199999,"change":0.06,"changeRate":0.002679,"amplitude":0.020335},"postHourTrading":{"tag":"盘后","latestPrice":23,"preClose":23.42,"latestTime":"19:50 EDT","volume":48145,"amount":1126756.8307,"timestamp":1778111425406,"change":-0.42,"changeRate":-0.017933,"amplitude":0.017933},"volumeRatio":1.17516,"impliedVol":1.0611,"impliedVolPercentile":0.9605},"requestUrl":"/m/hq/s/DFTX","defaultTab":"news","newsList":[{"id":"1180337716","title":"Definium Therapeutics 研发DT120口腔崩解片 针对广泛性焦虑症、重度抑郁症及其他严重脑健康疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1180337716","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180337716?lang=zh_cn&edition=full","pubTime":"2026-04-19 07:43","pubTimestamp":1776555796,"startTime":"0","endTime":"0","summary":"Definium Therapeutics公司正在积极推进其核心产品DT120口腔崩解片的研发进程,该药物主要瞄准广泛性焦虑症、重度抑郁症以及其他一系列严重的脑健康疾病的治疗领域。\n这款名为DT120 ODT的创新疗法,展现了公司在精神健康与神经系统疾病治疗方面的前沿探索。其研发策略聚焦于解决当前临床未满足的重大需求,旨在为深受相关疾病困扰的患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100586830","title":"Piper Sandler 首予 Definium Therapeutics 增持评级,目标价49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100586830","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100586830?lang=zh_cn&edition=full","pubTime":"2026-04-10 11:31","pubTimestamp":1775791902,"startTime":"0","endTime":"0","summary":"投资银行 Piper Sandler 宣布,正式开始对生物制药公司 Definium Therapeutics Inc 进行覆盖研究,并给予其“增持”评级。该机构设定了49美元的目标股价,显示出对其未来增长潜力的积极展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101183436","title":"Definium Therapeutics现金储备雄厚:截至2025年底持有4.116亿美元现金及投资,预计可支撑运营至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1101183436","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101183436?lang=zh_cn&edition=full","pubTime":"2026-02-27 05:45","pubTimestamp":1772142302,"startTime":"0","endTime":"0","summary":"生物制药公司Definium Therapeutics(股票代码:DFTX)宣布,截至2025年12月31日,公司持有的现金、现金等价物及投资总额达到4.116亿美元。这一强劲的财务状况预计将为公司的持续运营提供充足资金,支撑其业务发展直至2028年。\n巨额的资金储备为Definium Therapeutics推进其研发管线提供了坚实保障。公司专注于创新疗法的开发,充足的资金使其能够在不依赖额外融资的情况下,持续投入关键研发项目并拓展临床研究。这一财务优势不仅增强了公司的运营稳定性,也为其长期战略目标的实现奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":0.0531},{"period":"1month","weight":0.0832},{"period":"3month","weight":0.3153},{"period":"6month","weight":0.9753},{"period":"1year","weight":2.4198},{"period":"ytd","weight":0.6729}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":0.1036},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.0798},{"period":"1year","weight":0.2844},{"period":"ytd","weight":0.0614}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Definium Therapeutics, Inc.于2010年根据不列颠哥伦比亚省法律成立。他们是一家处于后期阶段的临床生物制药公司,正在开发新的候选产品来治疗大脑健康障碍。他们的使命是通过将科学的严谨性应用于迷幻药,锻造精神病学的新时代,目标是开发可获得的治疗方法,以大规模解锁愈合。他们正在开发一系列针对神经递质通路的创新候选产品,这些通路在大脑健康疾病中发挥着关键作用。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.037703},{"month":5,"riseRate":0.5,"avgChangeRate":0.001905},{"month":6,"riseRate":0.4,"avgChangeRate":-0.111207},{"month":7,"riseRate":0.8,"avgChangeRate":0.20763},{"month":8,"riseRate":0.2,"avgChangeRate":-0.091548},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Definium Therapeutics(DFTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Definium Therapeutics(DFTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}